TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T40474	Proto-oncogene c-Met	B0WLH8	N-(7-Methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide	Investigative	58056356	C17H12N4O2S	336.4	COC1=C(C=C2C=CC=NC2=C1)NC(=O)C3=CSC4=CN=CN=C43	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B1A4EI	(8S,16S)-3,16-Dihydroxy-9,10-seco-1,3,5(10)-cholestatrien-9-one	Investigative	9547398	C27H42O3	414.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3C[C@@H]([C@@H]([C@]3(CCC2=O)C)[C@H](C)CCCC(C)C)O	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B1BD8S	2-Fluoro-N'-[2-(1H-indol-3-yl)-2-oxoacetyl]benzohydrazide	Investigative	53328318	C17H12FN3O3	325.29	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC(=O)C3=CC=CC=C3F	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B1DY3G	2-(4-Methylpiperazin-1-yl)-8-phenylquinoxaline-6-carbonitrile	Investigative	44581757	C20H19N5	329.4	CN1CCN(CC1)C2=NC3=C(C=C(C=C3N=C2)C#N)C4=CC=CC=C4	IC50 = 60200 nM	Poor binder
T40474	Proto-oncogene c-Met	B1IH8M	N'-Phenyl-2-(1H-indole-3-yl)-2-oxoacetohydrazide	Investigative	2716301	C16H13N3O2	279.29	C1=CC=C(C=C1)NNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B1VO9R	Calicoferol E	Investigative	5283685	C27H42O2	398.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3CC[C@@H]([C@]3(CCC2=O)C)[C@H](C)CCCC(C)C	IC50 = 71500 nM	Poor binder
T40474	Proto-oncogene c-Met	B3QF8S	N-{5-[(3,4-Difluorophenyl)methyl]-1,3-thiazol-2-yl}-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide	Investigative	135886762	C21H16F2N4O2S	426.4	C1=CC=C2C(=C1)C(=O)NC(=N2)CCC(=O)NC3=NC=C(S3)CC4=CC(=C(C=C4)F)F	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B3T9QN	Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44219749	C24H29N7O5	495.5	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B43WPI	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2R)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325478	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B4G2QZ	Methyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44605035	C22H27N7O3	437.5	COC(=O)N1CCC(CC1)N2C3=C(C=N2)C(=NC(=N3)C4=CC=C(C=C4)N)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B4K5TJ	4-(3-((4-Hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(2-hydroxyethyl)benzamide	Investigative	44541014	C26H21N3O5	455.5	CN1C=C(C2=C(C=CN=C21)C3=CC=C(C=C3)C(=O)NCCO)/C=C\\4/C(=O)C5=C(C=CC=C5O4)O	IC50 = 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B4YXC8	7-[[(1R,2S,4Ar,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-5-methoxy-2-methyl-1,3-benzoxazol-6-ol	Investigative	76335685	C24H33NO3	383.5	C[C@H]1CC[C@@]2([C@H]([C@]1(C)CC3=C4C(=CC(=C3O)OC)N=C(O4)C)CCC=C2C)C	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B58TMC	[6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate	Investigative	24753787	C21H22ClN3O6S	479.9	CC1=C(C(=O)OC2=CC(=C(C=C12)Cl)OC(=O)N(C)C)CC3=CC(=CC=C3)NS(=O)(=O)NC	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B5C4MR	Tert-butyl N-[2-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-2-oxoethyl]carbamate	Investigative	137639657	C21H22BrN5O3	472.3	CC(C)(C)OC(=O)NCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B5RY4P	Chembl4173469	Investigative	145952077	C29H31N5O3S	529.7	CC(=O)N1CCC(CC1)NC2=CC=C(C=C2)C3=NNC4=C3CN(CC4)S(=O)(=O)C5=CC=CC6=CC=CC=C65	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B6LXB4	N-[2-(3-Chlorophenyl)ethyl]-2-(1H-indol-3-yl)-2-oxoacetamide	Investigative	53330630	C18H15ClN2O2	326.8	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NCCC3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B6SP0Y	N'-(4-Chlorophenyl)-2-(1H-indole-3-yl)-2-oxoacetohydrazide	Investigative	10805173	C16H12ClN3O2	313.74	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC3=CC=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B7J1GF	7-((4-Methylpiperazin-1-yl)methyl)-3-(thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole	Investigative	44414347	C20H22N4S	350.5	CN1CCN(CC1)CC2=CC3=C(CC4=C3NN=C4C5=CSC=C5)C=C2	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B7N1WR	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2S)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325479	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B84LCH	8-[2-(Diethylamino)ethoxy]-3-ethoxy-6,6-dimethylnaphtho[3,2-b][1]benzofuran-11-one	Investigative	54584802	C26H31NO4	421.5	CCN(CC)CCOC1=CC2=C(C=C1)C(=O)C3=C(C2(C)C)OC4=C3C=CC(=C4)OCC	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B8EHB1	Chembl4163204	Investigative	145961402	C26H31N5O3S	493.6	CC1=CC=C(C=C1)S(=O)(=O)N2CCC3=C(C2)C(=NN3)C4=CC=C(C=C4)NC5CCN(CC5)C(=O)C	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B8LTY1	N-[3-Fluoro-4-[[3-(3-morpholin-4-ylpropyl)-2-oxo-1H-imidazo[4,5-h][1,6]naphthyridin-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide	Investigative	118724399	C34H29F2N7O5	653.6	C1COCCN1CCCN2C3=C(C4=C(C=CC=N4)C(=N3)OC5=C(C=C(C=C5)NC(=O)C6=CC=CN(C6=O)C7=CC=C(C=C7)F)F)NC2=O	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	B9B8XW	1'-Methyl-5-[3-(quinolin-6-ylmethyl)triazolo[4,5-d]pyrimidin-5-yl]spiro[1H-indole-3,4'-piperidine]-2-one	Investigative	57399778	C27H24N8O	476.5	CN1CCC2(CC1)C3=C(C=CC(=C3)C4=NC=C5C(=N4)N(N=N5)CC6=CC7=C(C=C6)N=CC=C7)NC2=O	IC50 = 140000 nM	Poor binder
T40474	Proto-oncogene c-Met	B9GWJ2	N'-[2-(1H-Indol-3-yl)-2-oxoacetyl]benzohydrazide	Investigative	2716309	C17H13N3O3	307.3	C1=CC=C(C=C1)C(=O)NNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B9P0VS	N-[3-(Dimethylcarbamoyl)phenyl]-2-phenylmethoxy-4-(3-pyrrolidin-1-ylpropoxy)benzamide	Investigative	56678902	C30H35N3O4	501.6	CN(C)C(=O)C1=CC(=CC=C1)NC(=O)C2=C(C=C(C=C2)OCCCN3CCCC3)OCC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	B9RCI4	2-(2,6-Dichloro-phenylamino)-7-(3-diethylamino-propenyl)-1,6-dimethyl-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one	Investigative	9869943	C25H27Cl2N5O	484.4	CCN(CC)C/C=C/C1=C(C2=C(C3=C(C=C2)N=C(N3C)NC4=C(C=CC=C4Cl)Cl)C(=O)N1)C	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BA62QX	4-(4-Methyl-1H-indol-5-ylamino)-2-(3-oxo-3-(pyrrolidin-1-yl)prop-1-enyl)thieno[2,3-b]pyridine-5-carbonitrile	Investigative	24766030	C24H21N5OS	427.5	CC1=C(C=CC2=C1C=CN2)NC3=C4C=C(SC4=NC=C3C#N)/C=C/C(=O)N5CCCC5	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BACL08	N-[2-(4-Chlorophenyl)ethyl]-2-(1H-indol-3-yl)-2-oxoacetamide	Investigative	2226536	C18H15ClN2O2	326.8	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NCCC3=CC=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BB0Q7T	N'-(4-Bromophenyl)-2-(1H-indol-3-yl)-2-oxoacetohydrazide	Investigative	53330628	C16H12BrN3O2	358.19	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC3=CC=C(C=C3)Br	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BB7SV5	1-[4-(4-Amino-6-methylthieno[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea	Investigative	6540005	C21H15F4N5OS	461.4	CC1=C(C2=C(N=CN=C2S1)N)C3=CC=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BBE6T2	2-(1H-Indol-3-yl)-N'-(4-iodophenyl)-2-oxoacetohydrazide	Investigative	53330629	C16H12IN3O2	405.19	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC3=CC=C(C=C3)I	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BDK9R0	Calicoferol C	Investigative	10024683	C28H44O2	412.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3CC[C@@H]([C@]3(CC[C@H]2O)C)[C@H](C)CCC(=C)C(C)C	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BE1XL7	N-(4-Chlorobenzyl)-2-(1H-indol-3-yl)-2-oxoacetamide	Investigative	5304328	C17H13ClN2O2	312.7	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NCC3=CC=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BEMH30	Eucalyptin A	Investigative	70678116	C28H40O6	472.6	CC(C)CC(=O)C1=C(C(=C(C(=C1O)C=O)O)C[C@]2(CC[C@@H]3[C@@H]2[C@H]4[C@H](C4(C)C)CC[C@@]3(C)O)C)O	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BF2YG3	N-[2-(3,4-Dimethoxyphenyl)ethyl]-2-(1H-indol-3-yl)-2-oxoacetamide	Investigative	342168	C20H20N2O4	352.4	COC1=C(C=C(C=C1)CCNC(=O)C(=O)C2=CNC3=CC=CC=C32)OC	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BF32AR	Calicoferol B	Investigative	10047545	C27H44O3	416.6	CC1=C(C=C(C=C1)O)CC[C@@H]2[C@@H](CC[C@]3([C@H]2C[C@@H]([C@@H]3[C@H](C)CCCC(C)C)O)C)O	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BFQ79L	N'-[2-(1H-Indol-3-yl)-2-oxoacetyl]-4-(5-methyl-1,2,4-oxadiazol-3-yl)benzohydrazide	Investigative	53328320	C20H15N5O4	389.4	CC1=NC(=NO1)C2=CC=C(C=C2)C(=O)NNC(=O)C(=O)C3=CNC4=CC=CC=C43	IC50 = 95000 nM	Poor binder
T40474	Proto-oncogene c-Met	BG0N6H	N'-[1H-Indol-3-yl(oxo)acetyl]-4-nitrobenzohydrazide	Investigative	4269048	C17H12N4O5	352.3	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC(=O)C3=CC=C(C=C3)[N+](=O)[O-]	IC50 = 69000 nM	Poor binder
T40474	Proto-oncogene c-Met	BG37WO	Astrogorgiadiol B	Investigative	5283727	C27H44O2	400.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3CC[C@@H]([C@]3(CC[C@H]2O)C)[C@H](C)CCCC(C)C	IC50 = 78000 nM	Poor binder
T40474	Proto-oncogene c-Met	BGQE67	N'-[2-(1H-Indol-3-yl)-2-oxoacetyl]-4-methylbenzohydrazide	Investigative	53328118	C18H15N3O3	321.3	CC1=CC=C(C=C1)C(=O)NNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 = 95000 nM	Poor binder
T40474	Proto-oncogene c-Met	BHZF25	1-Benzyl-5-[(5-chloro-2-hydroxyanilino)methylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile	Investigative	4067150	C21H16ClN3O3	393.8	CC1=C(C(=O)N(C(=C1C=NC2=C(C=CC(=C2)Cl)O)O)CC3=CC=CC=C3)C#N	IC50 = 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BMP0C7	Tert-Butyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44605037	C25H33N7O3	479.6	CC(C)(C)OC(=O)N1CCC(CC1)N2C3=C(C=N2)C(=NC(=N3)C4=CC=C(C=C4)N)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BN3Y0E	3-[[5-Cyano-6-(cyclopentylamino)pyrimidin-4-yl]amino]-4-methyl-N-(1,2-oxazol-3-yl)benzamide	Investigative	11235063	C21H21N7O2	403.4	CC1=C(C=C(C=C1)C(=O)NC2=NOC=C2)NC3=C(C(=NC=N3)NC4CCCC4)C#N	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BNQ1U5	Tert-butyl N-[(2R)-3-methyl-1-oxo-1-[[4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]amino]butan-2-yl]carbamate	Investigative	137652990	C25H28F3N5O3	503.5	CC(C)[C@H](C(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=CC(=C3)C(F)(F)F)NC(=O)OC(C)(C)C	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BPV0N8	N'-[2-(1H-Indol-3-yl)-2-oxoacetyl]-4-methoxybenzohydrazide	Investigative	53328119	C18H15N3O4	337.3	COC1=CC=C(C=C1)C(=O)NNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 = 96000 nM	Poor binder
T40474	Proto-oncogene c-Met	BQ5GN3	7-((1H-Imidazol-1-yl)methyl)-3-(thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole	Investigative	44414322	C18H14N4S	318.4	C1C2=C(C=C(C=C2)CN3C=CN=C3)C4=C1C(=NN4)C5=CSC=C5	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BS5IC7	2-(1H-Indol-3-yl)-N-(4-methylbenzyl)-2-oxoacetamide	Investigative	7117329	C18H16N2O2	292.3	CC1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BSG8O3	N-(3-Chloro-benzyl)-2-(1H-indol-3-yl)-2-oxo-acetamide	Investigative	10686611	C17H13ClN2O2	312.7	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NCC3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BT9VH6	6-(2,9-Diazaspiro[5.5]undecan-9-Yl)-9h-Purine	Investigative	70789255	C14H20N6	272.35	C1CC2(CCN(CC2)C3=NC=NC4=C3NC=N4)CNC1	IC50 = 183000 nM	Poor binder
T40474	Proto-oncogene c-Met	BTH68Q	1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea	Investigative	6539985	C20H17N5OS	375.4	CC1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=CSC4=NC=NC(=C34)N	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BU6O8Q	2-(1H-Indol-3-yl)-N-[2-(4-methylphenyl)ethyl]-2-oxoacetamide	Investigative	12758175	C19H18N2O2	306.4	CC1=CC=C(C=C1)CCNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BVI90B	Chembl4276946	Investigative	134611886	C12H11Cl2N3O	284.14	CC1=NN(C(=C1C2=CC(=C(C=C2)Cl)Cl)N)C(=O)C	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BVSP96	Chembl4167104	Investigative	145954544	C28H30N6O3S	530.6	CC(=O)N1CCC(CC1)NC2=CC=C(C=C2)C3=NNC4=C3CN(CC4)S(=O)(=O)C5=CC=CC6=C5N=CC=C6	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BXU03W	2-{[(5-{[(Oxolan-2-yl)methyl]amino}-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-6-phenyl-3H,4H-thieno[2,3-d]pyrimidin-4-one	Investigative	17549086	C20H19N5O2S3	457.6	C1CC(OC1)CNC2=NN=C(S2)SCC3=NC4=C(C=C(S4)C5=CC=CC=C5)C(=O)N3	IC50 ~ 50000 nM	Poor binder
T40474	Proto-oncogene c-Met	BY7MP5	5-(1H-Indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazin-2-one	Investigative	118723185	C21H19N3O4	377.4	COC1=CC(=CC(=C1OC)OC)C2=NC(=CNC2=O)C3=CNC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BZ3Q2N	N'-[2-(1H-Indol-3-yl)-2-oxoacetyl]-4-(6-methylpyrazin-2-yl)oxybenzohydrazide	Investigative	53328321	C22H17N5O4	415.4	CC1=CN=CC(=N1)OC2=CC=C(C=C2)C(=O)NNC(=O)C(=O)C3=CNC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	BZR76B	Norlichexanthone	Investigative	5281657	C14H10O5	258.23	CC1=CC(=CC2=C1C(=O)C3=C(C=C(C=C3O2)O)O)O	IC50 ~ 100000 nM	Poor binder
T40474	Proto-oncogene c-Met	D08HGK	N-Benzyl-2-(1H-indol-3-yl)-2-oxo-acetamide	Investigative	3149447	C17H14N2O2	278.3	C1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=CC=CC=C32	IC50 ~ 100000 nM	Poor binder